Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 2;33(2):e287081.
doi: 10.1590/1413-785220253302e287081. eCollection 2025.

EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH SYSTEMIC SCLEROSIS TREATED AT A QUATERNARY HOSPITAL IN THE STATE OF SÃO PAULO

Pedro Henrique de Magalhães Tenório  1 , Rafaella Camilo de Oliveira  1 , Matheus Portilho Pinto Ribeiro  1 , Ramon Alves Queiroz  1 , Marcos Felipe Marcatto de Abreu  1
Affiliations

EPIDEMIOLOGICAL PROFILE OF PATIENTS WITH SYSTEMIC SCLEROSIS TREATED AT A QUATERNARY HOSPITAL IN THE STATE OF SÃO PAULO

Pedro Henrique de Magalhães Tenório et al. Acta Ortop Bras. .

Abstract
in English, Portuguese

Objective: To report the profile of patients diagnosed with systemic sclerosis and monitored in a four-year hospital in São Paulo.

Methods: Observational study with 51 patients, mostly composed of women. Descriptive statistics such as mean age, proportions (sex, ethnicity, form of the disease), and correlations between functional scores (HAQ, SHAQ, and Rodnan score) were extracted.

Results: The average age found was 49.96 ± 12.01 years. The time since diagnosis was 11.19 ± 10.16 years. When separated by sex, 25% of men presented the limited form, while 65.9% of women presented the localized form. There was a statistically significant correlation (p-value<0.01) between the Rodnan score and the HAQ score, with a value of 0.36 (CI: 0.09-0.58), as well as with the SHAQ score (value of 0.33; CI: 0.05-0.55, p-value=0.01). When evaluating the correlation between the Rodnan score and the Cochin functional scale, there was a statistically significant correlation (p-value<0.01), with a value of 0.38 (0.12-0.58).

Conclusion: According to the literature, this study showed the highest prevalence in women, and the predominant form is limited. Level of Evidence II; Cohort Study.

Objetivo: Relatar o perfil dos pacientes diagnosticados com esclerose sistêmica e acompanhados em um hospital quartenário paulista.

Métodos: Estudo observacional com 51 pacientes, composto majoritariamente por mulheres. Foram extraídas estatísticas descritivas como idade média, proporções (sexo, etnia, forma da doença) e correlações entre escores funcionais (HAQ, SHAQ e escore de Rodnan).

Resultados: A idade média encontrada foi de 49,96 ± 12,01 anos. O tempo desde o diagnóstico foi de 11,19 ± 10,16 anos. Quando separados por sexo, 25% dos homens apresentaram a forma limitada, enquanto 65,9% das mulheres apresentaram a forma localizada. Houve correlação estatisticamente significante (p-valor<0,01) entre o escore de Rodnan e a pontuação HAQ, com valor de 0,36 (IC: 0,09-0,58), bem como com a pontuação SHAQ (valor de 0,33; IC: 0,05-0,55, p-valor=0.01). Quando avaliada a correlação entre o escore de Rodnan e a escala funcional de Cochin, houve correlação estatisticamente significante (p-valor<0,01), com valor de 0,38 (0,12-0,58).

Conclusão: De acordo com a literatura, este estudo evidenciou a maior prevalência em mulheres e a forma predominante sendo a limitada. Nível de Evidência II; Estudo de Coorte.

Keywords: Epidemiological Profile; Epidemiology; Scleroderma, Systemic.

PubMed Disclaimer

Conflict of interest statement

All authors declare no potential conflict of interest related to this article.

Figures

Figure 1
Figure 1. Distribution of forms of the disease by gender.
Figure 2
Figure 2. Distribution of forms of the disease, by self-declared ethnicity.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Ingegnoli F, Ughi N, Mihai C. Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis. Best Pract Res Clin Rheumatol. 2018;32(2):223–240. doi: 10.1016/j.berh.2018.08.005. - DOI - PubMed
    1. Delisle VC, Hudson M, Baron M, Thombs BD. The Canadian Scleroderma Research Group A. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry. Clin Exp Rheumatol. 2014;32((6 Suppl 86)):S-10–S-14. - PubMed
    1. Morgan ND, Shah AA, Mayes MD, Domsic RT, Medsger TA, Jr, Steen VD, et al. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database. Medicine (Baltimore) 2017;96(51):e8980. doi: 10.1097/MD.0000000000008980. - DOI - PMC - PubMed
    1. Ferraz MB. Tradução para o português e validação do questionário para avaliar a capacidade funcional "Stanford Health Assessment Questionaire". São Paulo: Paulista School of Medicine, Federal University of São Paulo (UNIFESP); 1990. [doctorate]
    1. Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, et al. Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord. 2017;2(1):11–18. doi: 10.5301/jsrd.5000231. - DOI - PMC - PubMed

LinkOut - more resources